135 related articles for article (PubMed ID: 9328469)
1. Germline mutations of the CDKN2 gene in UK melanoma families.
Harland M; Meloni R; Gruis N; Pinney E; Brookes S; Spurr NK; Frischauf AM; Bataille V; Peters G; Cuzick J; Selby P; Bishop DT; Bishop JN
Hum Mol Genet; 1997 Nov; 6(12):2061-7. PubMed ID: 9328469
[TBL] [Abstract][Full Text] [Related]
2. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression.
Piccinin S; Doglioni C; Maestro R; Vukosavljevic T; Gasparotto D; D'Orazi C; Boiocchi M
Int J Cancer; 1997 Feb; 74(1):26-30. PubMed ID: 9036865
[TBL] [Abstract][Full Text] [Related]
3. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.
Holland EA; Beaton SC; Becker TM; Grulet OM; Peters BA; Rizos H; Kefford RF; Mann GJ
Oncogene; 1995 Dec; 11(11):2289-94. PubMed ID: 8570179
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
Kamb A; Shattuck-Eidens D; Eeles R; Liu Q; Gruis NA; Ding W; Hussey C; Tran T; Miki Y; Weaver-Feldhaus J
Nat Genet; 1994 Sep; 8(1):23-6. PubMed ID: 7987388
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds.
Flores JF; Pollock PM; Walker GJ; Glendening JM; Lin AH; Palmer JM; Walters MK; Hayward NK; Fountain JW
Oncogene; 1997 Dec; 15(24):2999-3005. PubMed ID: 9416844
[TBL] [Abstract][Full Text] [Related]
7. Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma.
Liu L; Lassam NJ; Slingerland JM; Bailey D; Cole D; Jenkins R; Hogg D
Oncogene; 1995 Jul; 11(2):405-12. PubMed ID: 7624155
[TBL] [Abstract][Full Text] [Related]
8. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.
Gruis NA; van der Velden PA; Sandkuijl LA; Prins DE; Weaver-Feldhaus J; Kamb A; Bergman W; Frants RR
Nat Genet; 1995 Jul; 10(3):351-3. PubMed ID: 7670475
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
Soufir N; Avril MF; Chompret A; Demenais F; Bombled J; Spatz A; Stoppa-Lyonnet D; Bénard J; Bressac-de Paillerets B
Hum Mol Genet; 1998 Feb; 7(2):209-16. PubMed ID: 9425228
[TBL] [Abstract][Full Text] [Related]
10. CDKN2A mutations in multiple primary melanomas.
Monzon J; Liu L; Brill H; Goldstein AM; Tucker MA; From L; McLaughlin J; Hogg D; Lassam NJ
N Engl J Med; 1998 Mar; 338(13):879-87. PubMed ID: 9516223
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of 9p21 deletions in UK melanoma families.
Mistry SH; Taylor C; Randerson-Moor JA; Harland M; Turner F; Barrett JH; Whitaker L; Jenkins RB; Knowles MA; Bishop JA; Bishop DT
Genes Chromosomes Cancer; 2005 Nov; 44(3):292-300. PubMed ID: 16032697
[TBL] [Abstract][Full Text] [Related]
12. Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families.
Yakobson E; Shemesh P; Azizi E; Winkler E; Lassam N; Hogg D; Brookes S; Peters G; Lotem M; Zlotogorski A; Landau M; Safro M; Shafir R; Friedman E; Peretz H
Eur J Hum Genet; 2000 Aug; 8(8):590-6. PubMed ID: 10951521
[TBL] [Abstract][Full Text] [Related]
13. Five novel somatic CDKN2/p16 mutations identified in melanoma, glioma and carcinoma of the pancreas. Mutations in brief no. 170. Online.
Gretarsdóttir S; Olafsdóttir GH; Borg A
Hum Mutat; 1998; 12(3):212. PubMed ID: 10651484
[TBL] [Abstract][Full Text] [Related]
14. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.
Fargnoli MC; Chimenti S; Keller G; Soyer HP; Dal Pozzo V; Höfler H; Peris K
J Invest Dermatol; 1998 Dec; 111(6):1202-6. PubMed ID: 9856841
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
[TBL] [Abstract][Full Text] [Related]
16. Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
Newton Bishop JA; Harland M; Bennett DC; Bataille V; Goldstein AM; Tucker MA; Ponder BA; Cuzick J; Selby P; Bishop DT
Br J Cancer; 1999 Apr; 80(1-2):295-300. PubMed ID: 10390011
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas.
Holland EA; Schmid H; Kefford RF; Mann GJ
Genes Chromosomes Cancer; 1999 Aug; 25(4):339-48. PubMed ID: 10398427
[TBL] [Abstract][Full Text] [Related]
18. CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families.
Gruis NA; Sandkuijl LA; van der Velden PA; Bergman W; Frants RR
Melanoma Res; 1995 Jun; 5(3):169-77. PubMed ID: 7640518
[TBL] [Abstract][Full Text] [Related]
19. Lack of germline CDK6 mutations in familial melanoma.
Shennan MG; Badin AC; Walsh S; Summers A; From L; McKenzie M; Goldstein AM; Tucker MA; Hogg D; Lassam N
Oncogene; 2000 Mar; 19(14):1849-52. PubMed ID: 10777219
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds.
Walker GJ; Hussussian CJ; Flores JF; Glendening JM; Haluska FG; Dracopoli NC; Hayward NK; Fountain JW
Hum Mol Genet; 1995 Oct; 4(10):1845-52. PubMed ID: 8595405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]